Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 31.39%745M | 34.61%529M | -48.64%265M | 23.43%627M | -44.88%-849M | -5.34%567M | 193.28%393M | 1,358.54%516M | 235.83%508M | 71.81%-586M |
| Net income from continuing operations | 28.86%692M | 12.74%584M | 35.92%507M | 19.96%541M | 23.20%-887M | 5.29%537M | 375.23%518M | -27.71%373M | -84.26%451M | -70.86%-1.16B |
| Operating gains losses | 13.33%-13M | -912.50%-65M | 220.83%29M | 48.21%83M | 612.50%114M | -157.69%-15M | -52.94%8M | -700.00%-24M | 154.55%56M | -82.98%16M |
| Depreciation and amortization | 300.00%16M | 266.67%11M | -25.00%3M | ---- | ---- | 33.33%4M | --3M | 0.00%4M | ---- | ---- |
| Remuneration paid in stock | -23.81%32M | 42.11%27M | 75.00%35M | -50.00%3M | -358.82%-78M | 366.67%42M | 1,800.00%19M | 0.00%20M | 112.50%6M | 26.09%-17M |
| Deferred tax | -200.00%-5M | --0 | -113.79%-4M | ---- | ---- | 112.50%5M | --62M | -49.12%29M | ---- | ---- |
| Other non cashItems | -184.93%-62M | -90.60%-284M | -42.97%142M | --2M | ---171M | 360.71%73M | ---149M | 403.66%249M | ---- | ---- |
| Change In working capital | 207.59%85M | 476.47%256M | -231.11%-447M | 60.00%-2M | -15.92%280M | -166.39%-79M | -1,071.43%-68M | 75.59%-135M | 99.83%-5M | 120.96%333M |
| -Change in receivables | 100.70%2M | 222.83%297M | -288.89%-119M | 285.71%130M | 262.89%259M | -543.75%-284M | --92M | --63M | ---70M | 18.46%-159M |
| -Change in payables and accrued expense | -62.56%76M | -54.29%-54M | -42.41%-319M | -303.08%-132M | -83.51%47M | 290.38%203M | ---35M | ---224M | --65M | 120.44%285M |
| -Change in other working capital | 250.00%7M | 110.40%13M | -134.62%-9M | ---- | ---- | -33.33%2M | ---125M | --26M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 31.39%745M | 34.61%529M | -48.64%265M | 23.43%627M | -44.88%-849M | -5.34%567M | 193.28%393M | 1,358.54%516M | 235.83%508M | 71.81%-586M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.40%-8M | -8.41%-490M | 1,500.00%84M | 0.00%-41M | 935.71%1.74B | -3,775.00%-1.32B | -452M | -20.00%-6M | -102.40%-41M | 229.23%168M |
| Net business purchase and sale | --52M | --0 | --6M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | 95.75%-56M | -36.22%-519M | --24M | ---- | ---- | -3,476.92%-1.32B | ---381M | --0 | ---- | ---- |
| Net other investing changes | 33.33%-4M | 140.85%29M | 1,000.00%54M | 0.00%-41M | -192.86%-82M | -100.00%-6M | ---71M | ---6M | ---41M | ---28M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.40%-8M | -8.41%-490M | 1,500.00%84M | 0.00%-41M | 935.71%1.74B | -3,775.00%-1.32B | ---452M | -20.00%-6M | -102.40%-41M | 229.23%168M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 41.88%-161M | 117.91%108M | 27.24%-422M | -27.02%-583M | -14.52%877M | 54.44%-277M | -350.00%-603M | -67.15%-580M | -63.93%-459M | -54.36%1.03B |
| Net issuance payments of debt | 113.68%750M | --617M | 7,680.00%389M | ---- | ---- | 640.00%351M | --0 | -96.43%5M | ---- | ---- |
| Net common stock issuance | ---69M | --0 | ---116M | 96.90%-10M | ---10M | --0 | --0 | --0 | ---323M | ---- |
| Net preferred stock issuance | --0 | --25M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash dividends paid | -13.87%-706M | -13.41%-702M | -14.03%-707M | -24.75%-630M | 14.75%1.23B | -18.32%-620M | -387.40%-619M | -17.42%-620M | 84.14%-505M | 495.00%1.07B |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | --0 | --0 | -9.76%37M | ---- | ---- |
| Net other financing activities | -1,600.00%-136M | 950.00%168M | 700.00%12M | -84.55%57M | -86.82%51M | 57.89%-8M | -44.83%16M | ---2M | -91.51%369M | 11.21%387M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 41.88%-161M | 117.91%108M | 27.24%-422M | -27.02%-583M | -14.52%877M | 54.44%-277M | -350.00%-603M | -67.15%-580M | -63.93%-459M | -54.36%1.03B |
| Net cash flow | ||||||||||
| Beginning cash position | -75.14%480M | -87.20%332M | -84.85%404M | 800.00%9M | -69.34%903M | -33.82%1.93B | 21,516.67%2.59B | -24.77%2.67B | -99.96%1M | 13.23%2.95B |
| Current changes in cash | 155.76%576M | 122.21%147M | -4.29%-73M | -62.50%3M | 190.79%1.77B | -3,925.93%-1.03B | ---662M | 82.19%-70M | -99.24%8M | 1,458.97%608M |
| Effect of exchange rate changes | 20.00%6M | 200.00%1M | 133.33%1M | ---- | ---- | --5M | ---1M | ---3M | ---- | ---- |
| End cash Position | 17.61%1.06B | -75.14%480M | -87.20%332M | 33.33%12M | 33.33%12M | -69.34%903M | 15,991.67%1.93B | -17.70%2.59B | -99.75%9M | 800.00%9M |
| Free cash from | 31.39%745M | 34.61%529M | -48.64%265M | 23.43%627M | -44.88%-849M | -5.34%567M | 193.28%393M | 1,328.57%516M | 231.27%508M | 71.80%-586M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.